Limit search to available items
Nearby Subjects are:
Result Page   Prev Next
Add Marked to Bag Add All On Page Add Marked to My Lists
Mark   Year Entries
 

Immunotherapies, Adoptive -- See Immunotherapy, Adoptive


Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  1
 

Immunotherapies, Adoptive Cellular -- See Immunotherapy, Adoptive


Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  1
 

Immunotherapies, Allergen -- See Desensitization, Immunologic


Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
  1
 

Immunotherapies, Passive -- See Immunization, Passive


Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER)
  1
  Immunotherapy -- 3 Related Subjects   3
Immunotherapy.   102
Immunotherapy, Active.   4
Immunotherapy, Active -- methods. : Immunologic adjuvant research / Antonio H. Benvenuto, editor  2009 1
Immunotherapy, Adoptive   4
 

Immunotherapy, Adoptive Cellular -- See Immunotherapy, Adoptive


Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
  1
Immunotherapy -- adverse effects   2
 

Immunotherapy, Allergen -- See Desensitization, Immunologic


Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
  1
Allergy -- Immunotherapy   8
Asthma -- Immunotherapy.   2
Autoimmune diseases -- Immunotherapy   3
Brain -- Tumors -- Immunotherapy : Translational immunotherapy of brain tumors / edited by John H. Sampson  2017 1
Cancer -- Immunotherapy.   59
Cancer -- Immunotherapy -- Complications   2
Cancer -- Immunotherapy -- Congresses. : Policy issues in the clinical development and use of immunotherapy for cancer treatment : proceedings of a workshop / Erin Balogh, Kimberly Maxfield, Margie Patlak, and Sharyl J. Nass, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine  2016 1
Cancer -- Immunotherapy -- Periodicals : Journal for immunotherapy of cancer  2013- 1
Immunotherapy -- Complications. : Managing immunotherapy related organ toxicities : a practical guide / Yinghong Wang, editor  2022 1
Immunotherapy -- Congresses : Immunotherapy in 2020 : visions and trends for targeting inflammatory disease / A. Radbruch [and others], editors  2007 1
Diabetes -- Immunotherapy -- Congresses. : Defining optimal immunotherapies for type 1 diabetes  2008 1
Digestive organs -- Cancer -- Immunotherapy : Immunotherapy for gastrointestinal malignancies / Ramakrishna Vadde, Ganji Purnachandra Nagaraju, editors  2020 1
Immunotherapy -- ethics. : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors  2004 1
Gastrointestinal system -- Cancer -- Immunotherapy   2
Genitourinary organs -- Cancer -- Immunotherapy : Neoadjuvant immunotherapy treatment of localized genitourinary cancers : multidisciplinary management / Andrea Necchi, Philippe E. Spiess, editors  2022 1
Gliomas -- Immunotherapy   2
Immunotherapy -- Handbooks, manuals, etc   2
HIV infections -- Immunotherapy. : Soluble factors mediating innate immune responses to HIV infection / edited by Massimo Alfano  2010 1
Infertility, Female -- Immunotherapy : Lymphocyte immunization therapy (LIT) in reproductive failures : new horizons / Mohan Raut, Mugdha Raut  2022 1
Immunotherapy -- legislation & jurisprudence. : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors  2004 1
Melanoma -- Immunotherapy. : M-VAX TM - a treatment for patients with advanced stage III melanoma : assessment report  2002 1
Immunotherapy -- Methods   32
Multiple sclerosis -- Immunotherapy   2
Mycoses -- Immunotherapy. : Antifungal agents : methods and protocols / edited by Erika J. Ernst and P. David Rogers  2005 1
 

Immunotherapy, Passive -- See Immunization, Passive


Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER)
  1
Immunotherapy -- Periodicals   20
Sarcoma -- Immunotherapy : Immunotherapy of sarcoma / Sandra P. D'Angelo, Seth M. Pollack, editors  2019 1
Immunotherapy -- Technological innovations : Nanoparticle-mediated immunotherapy / Tuan Vo-Dinh, editor  2021 1
Immunotherapy -- trends : Immunotherapy in 2020 : visions and trends for targeting inflammatory disease / A. Radbruch [and others], editors  2007 1
Tuberculosis -- Immunotherapy : Advances in host-directed therapies against tuberculosis / Petros C. Karakousis, Richard Hafner, Maria Laura Gennaro, editors  2021 1
Immunotherapy -- veterinary : Equine clinical immunology / [edited by] M. Julia B. Felippe  2016 1
 

Immunotoxicity -- See Immunotoxicology


  1
Immunotoxicologia. : Allergy and immunotoxicology in occupational health -- the next step / Takemi Otsuki, Mario Di Gioacchino, Claudia Petrarca, editors  2020 1
  Immunotoxicology -- 2 Related Subjects   2
Immunotoxicology.   9
Immunotoxicology -- Periodicals   3
Immunotoxicology -- Research -- Methodology : Investigative immunotoxicology / edited by Helen Tryphonas [and others]  2005 1
 

Immunotoxin -- See Immunotoxins


Semisynthetic conjugates of various toxic molecules, including RADIOACTIVE ISOTOPES and bacterial or plant toxins, with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; and ANTIGENS. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect
  1
Add Marked to Bag Add All On Page Add Marked to My Lists
Result Page   Prev Next